Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Imaging characteristics of cardiac metastases in patients with malignant melanoma.

Zitzelsberger T, Eigentler TK, Krumm P, Nikolaou K, Garbe C, Gawaz M, Klumpp B.

Cancer Imaging. 2017 Jul 1;17(1):19. doi: 10.1186/s40644-017-0122-8.

2.

Routine Computer Tomography Imaging for the Detection of Recurrences in High-Risk Melanoma Patients.

Park TS, Phan GQ, Yang JC, Kammula U, Hughes MS, Trebska-McGowan K, Morton KE, White DE, Rosenberg SA, Sherry RM.

Ann Surg Oncol. 2017 Apr;24(4):947-951. doi: 10.1245/s10434-017-5768-8. Epub 2017 Jan 31.

3.

Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients.

Lee AY, Droppelmann N, Panageas KS, Zhou Q, Ariyan CE, Brady MS, Chapman PB, Coit DG.

Ann Surg Oncol. 2017 Apr;24(4):939-946. doi: 10.1245/s10434-016-5642-0. Epub 2016 Nov 1.

PMID:
27804026
4.

Long-term follow-up for melanoma patients: is there any evidence of a benefit?

Rueth NM, Cromwell KD, Cormier JN.

Surg Oncol Clin N Am. 2015 Apr;24(2):359-77. doi: 10.1016/j.soc.2014.12.012. Epub 2015 Jan 24. Review.

5.

The role of ultrasound and ultrasound-guided fine needle aspiration biopsy of lymph nodes in patients with skin tumours.

Solivetti FM, Elia F, Santaguida MG, Guerrisi A, Visca P, Cercato MC, Di Carlo A.

Radiol Oncol. 2014 Jan 22;48(1):29-34. doi: 10.2478/raon-2013-0084. eCollection 2014 Mar.

6.

To what extent are current guidelines for cutaneous melanoma follow up based on scientific evidence?

Marciano NJ, Merlin TL, Bessen T, Street JM.

Int J Clin Pract. 2014 Jun;68(6):761-70. doi: 10.1111/ijcp.12393. Epub 2014 Feb 18. Review.

7.

Outpatient Follow-up and Secondary Prevention for Melanoma Patients.

Gamble RG, Jensen D, Suarez AL, Hanson AH, McLaughlin L, Duke J, Dellavalle RP.

Cancers (Basel). 2010 Jun 7;2(2):1178-97. doi: 10.3390/cancers2021178.

8.

A Global Review of Melanoma Follow-up Guidelines.

Trotter SC, Sroa N, Winkelmann RR, Olencki T, Bechtel M.

J Clin Aesthet Dermatol. 2013 Sep;6(9):18-26. Review.

9.

Variability in melanoma post-treatment surveillance practices by country and physician specialty: a systematic review.

Cromwell KD, Ross MI, Xing Y, Gershenwald JE, Royal RE, Lucci A, Lee JE, Cormier JN.

Melanoma Res. 2012 Oct;22(5):376-85. doi: 10.1097/CMR.0b013e328357d796. Review.

10.

Serum microRNAs as biomarkers for recurrence in melanoma.

Friedman EB, Shang S, de Miera EV, Fog JU, Teilum MW, Ma MW, Berman RS, Shapiro RL, Pavlick AC, Hernando E, Baker A, Shao Y, Osman I.

J Transl Med. 2012 Aug 2;10:155. doi: 10.1186/1479-5876-10-155.

11.

It is never too late: ultra-late recurrence of melanoma with distant metastases.

Mansour D, Kejariwal D.

BMJ Case Rep. 2012 Mar 8;2012. pii: bcr0120125474. doi: 10.1136/bcr.01.2012.5474.

12.

Utility of 3-year torso computed tomography and head imaging in asymptomatic patients with high-risk melanoma.

DeRose ER, Pleet A, Wang W, Seery VJ, Lee MY, Renzi S, Sullivan RJ, Atkins MB.

Melanoma Res. 2011 Aug;21(4):364-9. doi: 10.1097/CMR.0b013e3283471086.

13.

Racial differences in survival after surgical treatment for melanoma.

Collins KK, Fields RC, Baptiste D, Liu Y, Moley J, Jeffe DB.

Ann Surg Oncol. 2011 Oct;18(10):2925-36. doi: 10.1245/s10434-011-1706-3. Epub 2011 Apr 9.

14.

Site and timing of first relapse in stage III melanoma patients: implications for follow-up guidelines.

Romano E, Scordo M, Dusza SW, Coit DG, Chapman PB.

J Clin Oncol. 2010 Jun 20;28(18):3042-7. doi: 10.1200/JCO.2009.26.2063. Epub 2010 May 17.

15.
16.

Detection of melanoma nodal metastases; differences in detection between elderly and younger patients do not affect survival.

Kruijff S, Bastiaannet E, Suurmeijer AJ, Hoekstra HJ.

Ann Surg Oncol. 2010 Nov;17(11):3008-14. doi: 10.1245/s10434-010-1085-1. Epub 2010 May 5.

Supplemental Content

Support Center